HVC
STML

Healthcare Value Capital’s Stemline Therapeutics, Inc. STML Stock Holding History

Healthcare Value Capital’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-25,000
Closed -$221K – 27
2015
Q3 		$221K Hold
25,000
– – 0.32% 27
2015
Q2 		$294K Hold
25,000
– – 0.31% 29
2015
Q1 		$362K Buy
25,000
+8,536
+52% +$131K 0.39% 34
2014
Q4 		$281K Hold
16,464
– – 0.51% 23
2014
Q3 		$205K Hold
16,464
– – 0.2% 30
2014
Q2 		$242K Hold
16,464
– – 0.2% 32
2014
Q1 		$335K Hold
16,464
– – 0.22% 43
2013
Q4 		$323K Hold
16,464
– – 0.24% 36
2013
Q3 		$746K Buy
+16,464
New +$537K 0.65% 39

Other funds holding STML

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Healthcare Value Capital's STML Position: Q4 2015 in Review

Healthcare Value Capital sold out of Stemline Therapeutics, Inc. (STML) in Q4 2015, closing a stake of 25,000 shares — an estimated $221K sold.

Healthcare Value Capital first reported a position in STML in Q3 2013 and held it in 9 quarters. The position peaked at $746K in Q3 2013. 66 funds tracked by Wall St. Rank hold STML as of Q4 2015.

  • Healthcare Value Capital reported no remaining Stemline Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
  • Healthcare Value Capital sold 25,000 Stemline Therapeutics, Inc. shares in Q4 2015, an estimated $221K.
  • Healthcare Value Capital first reported a position in Stemline Therapeutics, Inc. in Q3 2013 and held it in 9 quarters.
  • Healthcare Value Capital's Stemline Therapeutics, Inc. position peaked at $746K in Q3 2013.
  • 66 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q4 2015.

Based on Healthcare Value Capital's 13F filing for Q4 2015, filed 16 Feb 2016.